AU2002221565A1 - Trefoil factor 2 (tff2) peptides with moiety attached to asn15 - Google Patents

Trefoil factor 2 (tff2) peptides with moiety attached to asn15

Info

Publication number
AU2002221565A1
AU2002221565A1 AU2002221565A AU2156502A AU2002221565A1 AU 2002221565 A1 AU2002221565 A1 AU 2002221565A1 AU 2002221565 A AU2002221565 A AU 2002221565A AU 2156502 A AU2156502 A AU 2156502A AU 2002221565 A1 AU2002221565 A1 AU 2002221565A1
Authority
AU
Australia
Prior art keywords
asn15
tff2
peptides
moiety attached
trefoil factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002221565A
Other languages
English (en)
Inventor
Asser Sloth Andersen
Soren E. Bjorn
Steen Seier Poulsen
Lars Thim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU2002221565A1 publication Critical patent/AU2002221565A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2002221565A 2000-12-08 2001-12-06 Trefoil factor 2 (tff2) peptides with moiety attached to asn15 Abandoned AU2002221565A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DKPA200001847 2000-12-08
DKPA200001847 2000-12-08
DKPA200001850 2000-12-09
DKPA200001850 2000-12-09
DKPA200100927 2001-06-14
DKPA200100927 2001-06-14
PCT/DK2001/000811 WO2002046226A2 (en) 2000-12-08 2001-12-06 Trefoil factor 2 (tff2) peptides with moiety attached to asn15

Publications (1)

Publication Number Publication Date
AU2002221565A1 true AU2002221565A1 (en) 2002-06-18

Family

ID=27222472

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002221565A Abandoned AU2002221565A1 (en) 2000-12-08 2001-12-06 Trefoil factor 2 (tff2) peptides with moiety attached to asn15

Country Status (5)

Country Link
US (2) US20020151472A1 (ja)
EP (1) EP1341817A2 (ja)
JP (1) JP2004515235A (ja)
AU (1) AU2002221565A1 (ja)
WO (1) WO2002046226A2 (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221840B1 (en) * 1991-02-14 2001-04-24 The General Hospital Corporation Intestinal trefoil proteins
US6525018B1 (en) * 1999-05-17 2003-02-25 The General Hospital Corp. Treating eye disorders using intestinal trefoil proteins
US20030186882A1 (en) * 2001-07-31 2003-10-02 Podolsky Daniel K. Methods and compositions for treating and preventing distal bowel lesions
US20030185838A1 (en) * 2001-11-28 2003-10-02 Podolsky Daniel K. Methods and compositions for treating lesions of the respiratory epithelium
US20060189526A1 (en) * 2002-04-24 2006-08-24 Podolsky Daniel K Compositions containing an intestinal trefoil peptide and a mucoadhesive
US20040171544A1 (en) * 2001-04-24 2004-09-02 Barker Nicholas P. Trefoil domain-containing polypeptides and uses thereof
US20030105016A1 (en) * 2001-09-06 2003-06-05 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
US7538082B2 (en) 2001-04-24 2009-05-26 The General Hospital Corporation Methods and compositions for treating oral and esophageal lesions
WO2002102403A1 (en) * 2001-06-14 2002-12-27 Novo Nordisk A/S Mucosal repair by tff dimer peptides
US20030181384A1 (en) * 2001-09-06 2003-09-25 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
MXPA04003267A (es) * 2001-10-05 2004-07-08 Gen Hospital Corp Metodos y composiciones para tratar lesiones dermicas.
JP2005532988A (ja) * 2001-11-28 2005-11-04 ザ ジェネラル ホスピタル コーポレーション 呼吸上皮の病変を治療するための方法および組成物
WO2004039961A2 (en) * 2002-10-31 2004-05-13 The Gi Company, Inc. Trefoil domain-containing polypeptides and uses thereof
US20060188471A1 (en) * 2002-10-31 2006-08-24 Podolsky Daniel K Methods of treating epithelial lesions
WO2004048604A1 (ja) * 2002-11-22 2004-06-10 Eisai Co., Ltd. Gwt1遺伝子産物の酵素活性を阻害する化合物をスクリーニングする方法
WO2004058307A1 (en) * 2002-12-18 2004-07-15 Wyeth Methods for screening, treating and diagnosing inflammatory bowel disease and compositions thereof
US6984628B2 (en) 2003-07-15 2006-01-10 Allergan, Inc. Ophthalmic compositions comprising trefoil factor family peptides
ATE550041T1 (de) 2004-01-21 2012-04-15 Novo Nordisk Healthcare Ag Transglutaminase-vermittelte konjugation von peptiden
JP3906471B1 (ja) 2004-09-28 2007-04-18 大塚製薬株式会社 カルボスチリル化合物
US8075771B2 (en) * 2005-02-17 2011-12-13 E. I. Du Pont De Nemours And Company Apparatus for magnetic field gradient enhanced centrifugation
JP2008545437A (ja) * 2005-06-06 2008-12-18 ワイス 炎症性腸疾患についての末梢血単核細胞の発現プロフィール
EP2083826A4 (en) * 2006-11-07 2010-09-22 Protelogiecs Ltd PYRIMIDINE DERIVATIVES AS POSH AND POSH-AP HEMMER
EP4065602A4 (en) * 2019-11-26 2023-12-27 Alkahest, Inc. METHODS AND COMPOSITIONS FOR TREATING DISORDERS ASSOCIATED WITH AGING WITH MODULATORS OF THE TREFOIL FACTOR 2 FAMILY ELEMENT
EP4329786A1 (en) 2021-04-30 2024-03-06 KaliVir Immunotherapeutics, Inc. Oncolytic viruses for modified mhc expression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK6893D0 (da) * 1993-01-21 1993-01-21 Novo Nordisk As Peptid
PT777687E (pt) * 1994-08-26 2006-10-31 Novo Nordisk As Dimeros do peptideo com uma estrutura em forma de folha de trevo

Also Published As

Publication number Publication date
WO2002046226A3 (en) 2002-10-03
WO2002046226A2 (en) 2002-06-13
US20060111278A1 (en) 2006-05-25
JP2004515235A (ja) 2004-05-27
US20020151472A1 (en) 2002-10-17
EP1341817A2 (en) 2003-09-10

Similar Documents

Publication Publication Date Title
AU2002221565A1 (en) Trefoil factor 2 (tff2) peptides with moiety attached to asn15
AU2001231532A1 (en) Improved interleukin 10
AU4524401A (en) Receptor-selective somatostatin analogs
AU2002222485A1 (en) Multi-purpose structure
EP1222212A4 (en) MUTANTS OF IL-13
AU2001252367A1 (en) Improvements relating to computer systems
AU2002215070A1 (en) Two-stroke engine
GB9701669D0 (en) Improvements to structure
EP0885834A3 (en) Lightweight jack
AU3739400A (en) Flint polypeptide analogs
AU8351198A (en) Improvements relating to connection devices
AU5065698A (en) Improvements to gas-masks
AU4972299A (en) Interferon alpha hybrids
AU1873499A (en) Semi-submersible structure
AU6550800A (en) Hepoxilin analogs
AU8453598A (en) Mcp-1 analogs
AUPP689598A0 (en) Improvements relating to temporary structures
AU3086800A (en) Injection-administered antiviral preparation
AU2002333947A1 (en) Improvements to surface picking techniques
AU6421499A (en) Carburetor
AU2337801A (en) Angiopoietin analogs
GB9926778D0 (en) Improvements relating to maps
AU2002347355A1 (en) Magnesium diboride superconductors
AU9084198A (en) Improvements relating to mechanical manipulators
GB2322685B (en) Improvements relating to fluid-powered cylinders